These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30318855)

  • 1. The influence of esmolol on right ventricular function in early experimental endotoxic shock.
    van Loon LM; van der Hoeven JG; Veltink PH; Lemson J
    Physiol Rep; 2018 Sep; 6(19):e13882. PubMed ID: 30318855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Blockade attenuates renal blood flow in experimental endotoxic shock by reducing perfusion pressure.
    van Loon LM; Rongen GA; van der Hoeven JG; Veltink PH; Lemson J
    Physiol Rep; 2019 Dec; 7(23):e14301. PubMed ID: 31814327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart rate reduction with esmolol is associated with improved arterial elastance in patients with septic shock: a prospective observational study.
    Morelli A; Singer M; Ranieri VM; D'Egidio A; Mascia L; Orecchioni A; Piscioneri F; Guarracino F; Greco E; Peruzzi M; Biondi-Zoccai G; Frati G; Romano SM
    Intensive Care Med; 2016 Oct; 42(10):1528-1534. PubMed ID: 27101380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock.
    Aboab J; Sebille V; Jourdain M; Mangalaboyi J; Gharbi M; Mansart A; Annane D
    Intensive Care Med; 2011 Aug; 37(8):1344-51. PubMed ID: 21567116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial.
    Morelli A; Ertmer C; Westphal M; Rehberg S; Kampmeier T; Ligges S; Orecchioni A; D'Egidio A; D'Ippoliti F; Raffone C; Venditti M; Guarracino F; Girardis M; Tritapepe L; Pietropaoli P; Mebazaa A; Singer M
    JAMA; 2013 Oct; 310(16):1683-91. PubMed ID: 24108526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic and anti-inflammatory effects of early esmolol use in hyperkinetic septic shock: a pilot study.
    Levy B; Fritz C; Piona C; Duarte K; Morelli A; Guerci P; Kimmoun A; Girerd N
    Crit Care; 2021 Jan; 25(1):21. PubMed ID: 33413583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut and sublingual microvascular effect of esmolol during septic shock in a porcine model.
    Jacquet-Lagrèze M; Allaouchiche B; Restagno D; Paquet C; Ayoub JY; Etienne J; Vandenesch F; Dauwalder O; Bonnet JM; Junot S
    Crit Care; 2015 Jun; 19(1):241. PubMed ID: 26041462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of esmolol on fluid responsiveness and hemodynamic parameters in patients with septic shock].
    Tao Y; Jingyi W; Xiaogan J; Weihua L; Xiaoju J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Nov; 27(11):885-9. PubMed ID: 27132454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvascular effects of heart rate control with esmolol in patients with septic shock: a pilot study.
    Morelli A; Donati A; Ertmer C; Rehberg S; Kampmeier T; Orecchioni A; D'Egidio A; Cecchini V; Landoni G; Pietropaoli P; Westphal M; Venditti M; Mebazaa A; Singer M
    Crit Care Med; 2013 Sep; 41(9):2162-8. PubMed ID: 23873274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esmolol for septic shock: more than just heart rate control?
    Orbegozo Cortes D; Njimi H; Dell'Anna AM; Taccone FS
    Minerva Anestesiol; 2014 Feb; 80(2):254-8. PubMed ID: 24500140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esmolol Administration to Control Tachycardia in an Ovine Model of Peritonitis.
    Hosokawa K; Su F; Taccone FS; Post EH; Pereira AJ; Herpain A; Creteur J; Vincent JL
    Anesth Analg; 2017 Dec; 125(6):1952-1959. PubMed ID: 28708664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of esmolol on systemic hemodynamics and heart rate variability measured using the Analgesia/Nociception Index in resuscitated piglets with Pseudomonas aeruginosa septic shock.
    Boselli E; Jacquet-Lagrèze M; Ayoub JY; Bouvet L; Dauwalder O; Mansour C; Margez T; Paquet C; Restagno D; Allaouchiche B; Bonnet-Garin JM; Junot S
    J Vet Emerg Crit Care (San Antonio); 2018 Sep; 28(5):447-456. PubMed ID: 30074662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Esmolol in Treatment of Patients with Septic Shock.
    Du W; Wang XT; Long Y; Liu DW
    Chin Med J (Engl); 2016 Jul; 129(14):1658-65. PubMed ID: 27411452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dexmedetomidine and esmolol on systemic hemodynamics and exogenous lactate clearance in early experimental septic shock.
    Hernández G; Tapia P; Alegría L; Soto D; Luengo C; Gomez J; Jarufe N; Achurra P; Rebolledo R; Bruhn A; Castro R; Kattan E; Ospina-Tascón G; Bakker J
    Crit Care; 2016 Aug; 20(1):234. PubMed ID: 27480413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of low doses of esmolol on cardiac and vascular function in experimental septic shock.
    Wei C; Louis H; Schmitt M; Albuisson E; Orlowski S; Levy B; Kimmoun A
    Crit Care; 2016 Dec; 20(1):407. PubMed ID: 27998289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant use of beta-1 adrenoreceptor blocker and norepinephrine in patients with septic shock.
    Balik M; Rulisek J; Leden P; Zakharchenko M; Otahal M; Bartakova H; Korinek J
    Wien Klin Wochenschr; 2012 Aug; 124(15-16):552-6. PubMed ID: 22815003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infusion of esmolol attenuates lipopolysaccharide-induced myocardial dysfunction.
    Wang Z; Wu Q; Nie X; Guo J; Yang C
    J Surg Res; 2016 Jan; 200(1):283-9. PubMed ID: 26316443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic Effects, Safety, and Feasibility of Intravenous Esmolol Infusion During Takotsubo Cardiomyopathy With Left Ventricular Outflow Tract Obstruction: Results From A Multicenter Registry.
    Santoro F; Ieva R; Ferraretti A; Fanelli M; Musaico F; Tarantino N; Martino LD; Gennaro LD; Caldarola P; Biase MD; Brunetti ND
    Cardiovasc Ther; 2016 Jun; 34(3):161-6. PubMed ID: 26946520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β1-Adrenergic Inhibition Improves Cardiac and Vascular Function in Experimental Septic Shock.
    Kimmoun A; Louis H; Al Kattani N; Delemazure J; Dessales N; Wei C; Marie PY; Issa K; Levy B
    Crit Care Med; 2015 Sep; 43(9):e332-40. PubMed ID: 25962080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Esmolol improves clinical outcome and tissue oxygen metabolism in patients with septic shock through controlling heart rate].
    Xinqiang L; Weiping H; Miaoyun W; Wenxin Z; Wenqiang J; Shenglong C; Juhao Z; Hongki Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Sep; 27(9):759-63. PubMed ID: 26955704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.